Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Suzuki

Showing results (141-150 of 334) with videos related to

Pageof 34
Sort By:
Radiation Medicine|July 19, 2003
Effects of p53 status and wortmannin treatment on potentially lethal damage repair, with emphasis on the response of intratumor quiescent cellsShin-ichiro Masunaga, Akihisa Takahashi, Ken Ohnishi, et al.
Journal of Radiation Research|December 1, 2010
An alternative mechanism for radioprotection by dimethyl sulfoxide; possible facilitation of DNA double-strand break repairGenro Kashino, Yong Liu, Minoru Suzuki, et al.
Journal of Radiation Research|July 1, 2020
An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed 10B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemnessShin-Ichiro Masunaga, Yu Sanada, Keizo Tano, et al.
Journal of Radiation Research|October 26, 2012
Wortmannin efficiently suppresses the recovery from radiation-induced damage in pimonidazole-unlabeled quiescent tumor cell populationShin-Ichiro Masunaga, Yoshinori Sakurai, Hiroki Tanaka, et al.
Journal of Radiation Research|February 10, 2023
The impact of TP53 status of tumor cells including the type and the concentration of administered 10B delivery agents on compound biological effectiveness in boron neutron capture therapyShin-Ichiro Masunaga, Yu Sanada, Takushi Takata, et al.
Neuro-Oncology|May 13, 2021
Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-upSatoshi Takai, Masahiko Wanibuchi, Shinji Kawabata, et al.
Biomedical Physics & Engineering Express|January 9, 2025
Evaluation of dose calculation method with a combination of Monte Carlo method and removal-diffusion equation in heterogeneous geometry for boron neutron capture therapyMai Nojiri, Takushi Takata, Akinori Sasaki, et al.
The Tohoku Journal of Experimental Medicine|November 12, 2003
Pharmacological mechanism in slip-down behavior of miceYutaka Masuda, Minoru Suzuki, Takaubu Takemura, et al.
Radiation Oncology (London, England)|December 17, 2009
Role of p53 mutation in the effect of boron neutron capture therapy on oral squamous cell carcinomaYusei Fujita, Itsuro Kato, Soichi Iwai, et al.
Biomaterials|February 14, 2012
Pharmacokinetics of core-polymerized, boron-conjugated micelles designed for boron neutron capture therapy for cancerShogo Sumitani, Motoi Oishi, Tatsuya Yaguchi, et al.
Pageof 34

Showing results (141-150 of 334) with videos related to

Sort By:
Pageof 34
Radiation Medicine|July 19, 2003
Effects of p53 status and wortmannin treatment on potentially lethal damage repair, with emphasis on the response of intratumor quiescent cellsShin-ichiro Masunaga, Akihisa Takahashi, Ken Ohnishi, et al.
Journal of Radiation Research|December 1, 2010
An alternative mechanism for radioprotection by dimethyl sulfoxide; possible facilitation of DNA double-strand break repairGenro Kashino, Yong Liu, Minoru Suzuki, et al.
Journal of Radiation Research|July 1, 2020
An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed 10B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemnessShin-Ichiro Masunaga, Yu Sanada, Keizo Tano, et al.
Journal of Radiation Research|October 26, 2012
Wortmannin efficiently suppresses the recovery from radiation-induced damage in pimonidazole-unlabeled quiescent tumor cell populationShin-Ichiro Masunaga, Yoshinori Sakurai, Hiroki Tanaka, et al.
Journal of Radiation Research|February 10, 2023
The impact of TP53 status of tumor cells including the type and the concentration of administered 10B delivery agents on compound biological effectiveness in boron neutron capture therapyShin-Ichiro Masunaga, Yu Sanada, Takushi Takata, et al.
Neuro-Oncology|May 13, 2021
Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-upSatoshi Takai, Masahiko Wanibuchi, Shinji Kawabata, et al.
Biomedical Physics & Engineering Express|January 9, 2025
Evaluation of dose calculation method with a combination of Monte Carlo method and removal-diffusion equation in heterogeneous geometry for boron neutron capture therapyMai Nojiri, Takushi Takata, Akinori Sasaki, et al.
The Tohoku Journal of Experimental Medicine|November 12, 2003
Pharmacological mechanism in slip-down behavior of miceYutaka Masuda, Minoru Suzuki, Takaubu Takemura, et al.
Radiation Oncology (London, England)|December 17, 2009
Role of p53 mutation in the effect of boron neutron capture therapy on oral squamous cell carcinomaYusei Fujita, Itsuro Kato, Soichi Iwai, et al.
Biomaterials|February 14, 2012
Pharmacokinetics of core-polymerized, boron-conjugated micelles designed for boron neutron capture therapy for cancerShogo Sumitani, Motoi Oishi, Tatsuya Yaguchi, et al.
Pageof 34